The relationship between plasma atherogenic index and long-term outcomes after endovascular intervention in superficial femoral artery lesions

被引:1
|
作者
Altunova, Mehmet [1 ,4 ]
Karakayali, Muammer [2 ]
Karakan, Ceren Yildirim [1 ]
Karakurt, Seda Tukenmez [1 ]
Demirci, Gokhan [1 ]
Aslan, Serkan [1 ]
Guler, Arda [1 ]
Evsen, Ali [3 ]
Erturk, Mehmet [1 ]
机构
[1] Univ Hlth Sci, Mehmet Akif Ersoy Thorac & Cardiovasc Surg Trainin, Dept Cardiol, Istanbul, Turkiye
[2] Kafkas Univ, Fac Med, Dept Cardiol, Kars, Turkiye
[3] Dicle Univ, Fac Med, Dept Cardiol, Diyarbakir, Turkiye
[4] Istanbul Mehmet Akif Ersoy Thoracicm & Cardiovasc, Cardiol Dept, TR-34290 Istanbul, Turkiye
关键词
Plasma atherogenic index; peripheral arterial disease; major adverse limb events; BARE-METAL STENTS; COVERED STENTS; RISK-FACTORS; CHOLESTEROL; DISEASE; RATIO;
D O I
10.1177/17085381231193494
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objectives Peripheral arterial disease (PAD) results from the systemic atherosclerotic process. In this study, we aimed to determine the relationship between plasma atherogenic index (AIP), a ratio of molar concentrations of triglycerides to HDL-cholesterol, and long-term outcomes after endovascular therapy (EVT) in patients with superficial femoral artery (SFA) stenosis. Methods We retrospectively evaluated 673 patients who underwent EVT for PAD in our tertiary center between January 2015 and December 2020. In the receiver operating characteristic (ROC) curve analysis, the AIP value with the optimum cutoff value was determined as 0.576 to detect the presence of major adverse limb events (MALEs). Patients were divided into two groups according to low AIP (<0.576 as group 1) and high AIP (>0.576 as group 2). Results Among the major endpoints, long-term restenosis rates were significantly higher in patients in the high-AIP group than in the low-AIP group (p<.001). The lower extremity amputation rate was not statistically significant between the two groups. All-cause mortality rate (54 (31.6) versus 117 (68.4), p<.001) was significantly higher in patients in the high-AIP group than in the low-AIP group. In addition, the MALE rate (94 (29.2) versus 218 (62.1), p<.001) was significantly higher in patients in the high-AIP group than in those in the low-AIP group. Conclusions In conclusion, we found that AIP is a significant independent predictor of long-term MALE in patients who underwent EVT for SFA.
引用
收藏
页码:310 / 319
页数:10
相关论文
共 50 条
  • [21] Mid-term outcome after endovascular therapy in the superficial femoral and popliteal artery using long stents
    Schoenefeld, Eva
    Donas, Konstantinos P.
    Schoenefeld, Thomas
    Osada, Nani
    Austermann, Martin
    Torsello, Giovanni
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2012, 41 (01) : 49 - 56
  • [22] ECONOMIC ANALYSIS OF ENDOVASCULAR STENTING FOR PERIPHERAL ARTERIAL DISEASE IN LONG LESIONS OF THE SUPERFICIAL FEMORAL ARTERY
    Chu, K.
    Hay, J. W.
    VALUE IN HEALTH, 2010, 13 (03) : A165 - A165
  • [23] Long-term outcome after percutaneous peripheral intervention vs medical treatment for patients with superficial femoral artery occlusive disease
    Kamiya, Chizuko
    Sakamoto, Shingo
    Tamori, Yuiichi
    Yoshimuta, Tsuyoshi
    Higashi, Masahiro
    Tanaka, Ryoichi
    Akutsu, Koichi
    Takeshita, Satoshi
    CIRCULATION JOURNAL, 2008, 72 (05) : 734 - 739
  • [24] Long-Term Outcomes of Common Femoral Artery Stenting
    Nasr, Bahaa
    Kaladji, Adrien
    Vent, Pierre-Alexandre
    Chaillou, Philippe
    Costargent, Alain
    Quillard, Thibault
    Goueffic, Yann
    ANNALS OF VASCULAR SURGERY, 2017, 40 : 10 - 18
  • [25] LONG-TERM RESULTS WITH THE PALMAZ STENT IN THE SUPERFICIAL FEMORAL-ARTERY
    BERGERON, P
    PINOT, JJ
    POYEN, V
    BENICHOU, H
    KHANOYAN, P
    RUDONDY, P
    WANG, Y
    CHIARANDINI, S
    ELHUSSEIN, R
    LARROUDE, L
    PELISSIER, R
    JOURNAL OF ENDOVASCULAR SURGERY, 1995, 2 (02): : 161 - 167
  • [26] Efficacy of Viabahn® in the treatment of severe superficial femoral artery lesions:: Which factors influence long-term patency?
    Alimi, Y. S.
    Hakam, Z.
    Hartung, O.
    Boufi, M.
    Barthelemy, P.
    Aissi, K.
    Dubuc, M.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2008, 35 (03) : 346 - 352
  • [27] Long-term Outcomes After Endovascular Recanalization in Patients with Chronic Carotid Artery Occlusion
    Kao, Hsien-Li
    Hung, Chi-Sheng
    Li, Hung-Yuan
    Yeh, Chih-Fan
    Huang, Ching-Chang
    Chen, Ying-Hsien
    Tang, Sung-Chun
    Chao, Chi-Chao
    Lin, Mao-Shin
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 122 (10): : 1779 - 1783
  • [28] Patient and limb outcomes 10 years after endovascular revascularization of the superficial femoral artery for peripheral artery disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) study
    Kinlay, Scott
    Sobieszczyk, Piotr
    Eisenhauer, Andrew C.
    Ostrowski, Simon
    Todoran, Thomas M.
    VASCULAR MEDICINE, 2023, 28 (04) : 290 - 298
  • [29] Association between sex and long-term outcomes of endovascular treatment for peripheral artery disease
    Ramkumar, Niveditta
    Suckow, Bjoern. D. D.
    Behrendt, Christian-Alexander
    Mackenzie, Todd. A. A.
    Sedrakyan, Art
    Brown, Jeremiah. R. R.
    Goodney, Philip. P. P.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2023, 101 (05) : 877 - 887
  • [30] Outcomes of interventions for recurrent disease after endoluminal intervention for superficial femoral artery disease
    Davies, Mark G.
    Bismuth, Jean
    Saad, Wael E.
    Naoum, Joseph J.
    Peden, Eric K.
    Lumsden, Alan B.
    JOURNAL OF VASCULAR SURGERY, 2010, 52 (02) : 331 - 339